About 700,000 people in Italy are affected by Alzheimerās disease; this form of dementia, which represents the third cause of death in Europe and one of the leading causes of disability on a global scale, also costs around 15.6 billion euros a year, 80% of which is borne directly by patients and their families. These are some of the data that emerged during the conference āAlzheimerās and neuroscience: a priority for the countryā underway in the Chamber of Deputies.
The meeting follows the birth of the Parliamentary Intergroup for Neuroscience and Alzheimerās. āThe main objective is to shine a light on these pathologies, not only for the increase that has been recorded as a consequence of the increase in the demographic age in our country, but for all the effects that these pathologies entail not only on the patient but also on family membersā, said Annarita Patriarca, deputy and co-promoter of the Parliamentary Intergroup for Neuroscience and Alzheimerās.
āFor us it is necessary to be able to guarantee homogeneity of access to quality care throughout the national territory and above all a home care system that works well throughout the national territoryā, āWe plan to work in such a way as to bring in this field what are the indications of science and patient associationsā, added Beatrice Lorenzin, senator and co-promoter of the Parliamentary Intergroup for Neuroscience and Alzheimerās. āWe will try to intervene on the organization of territorial networks, on the organization of diagnostics, on the formation of a regulatory system that is able to support the impact of the new drugs that will arrive, on the training of general practitioners who must be those who they allow us to reach patients when the disease is in an early stage,ā concluded Lorenzin.
breaking latest news Ā© Copyright ANSA